Trinity Biotech plc each representing 4 A Ordinary Shares (TRIB): Price and Financial Metrics


Trinity Biotech plc each representing 4 A Ordinary Shares (TRIB)

Today's Latest Price: $4.47 USD

0.15 (-3.25%)

Updated Dec 4 4:00pm

Add TRIB to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TRIB Stock Summary

  • Trinity Biotech Plc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 98.46% of US listed stocks.
  • Over the past twelve months, TRIB has reported earnings growth of -186.63%, putting it ahead of only 10.59% of US stocks in our set.
  • The volatility of Trinity Biotech Plc's share price is greater than that of 89.77% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Trinity Biotech Plc are QUAD, AVYA, GLP, CNR, and MRC.
  • TRIB's SEC filings can be seen here. And to visit Trinity Biotech Plc's official web site, go to www.trinitybiotech.com.

TRIB Stock Price Chart Interactive Chart >

Price chart for TRIB

TRIB Price/Volume Stats

Current price $4.47 52-week high $4.94
Prev. close $4.62 52-week low $0.56
Day low $4.36 Volume 189,700
Day high $4.73 Avg. volume 669,130
50-day MA $2.88 Dividend yield N/A
200-day MA $2.03 Market Cap 107.46M

Trinity Biotech plc each representing 4 A Ordinary Shares (TRIB) Company Bio


Trinity Biotech plc develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The company was founded in 1992 and is based in Bray, Ireland.


TRIB Latest News Stream


Event/Time News Detail
Loading, please wait...

TRIB Latest Social Stream


Loading social stream, please wait...

View Full TRIB Social Stream

Latest TRIB News From Around the Web

Below are the latest news stories about Trinity Biotech Plc that investors may wish to consider to help them evaluate TRIB as an investment opportunity.

Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q2 2020 Results - Earnings Call Transcript

Trinity Biotech plc (TRIB) Q2 2020 Earnings Conference Call Aug 25, 2020, 11:00 AM ET Company Participants Kevin Tansley - CFO Ronan O'Caoimh - Chairman & CEO Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Jim Sidoti - Sidoti & Company William Lapp -...

SA Transcripts on Seeking Alpha | August 25, 2020

Trinity Biotech files fast-track submission for Covid-19 antibody test

Company is also working on a second test to detect antibodies in just 12 minutes

The Irish Times | August 21, 2020

Trinity Biotech submits for EUA for COVID-19 antibody test

Trinity Biotech ([[TRIB]] -6.4%) has filed for FDA Emergency Use Authorization ((EUA)) for its COVID-19 IgG ELISA antibody test.EUA submission allows the company to begin marketing the product immediately.In addition, the Company is also developing a rapid point-of-care Covid-19 finger prick test, to detect antibodies to the virus that can...

Seeking Alpha | August 20, 2020

Why Trinity Biotech's Stock Is Trading Lower Today

Trinity Biotech (NASDAQ: TRIB) shares are trading lower on Monday after the company's subsidiary Primus Corp announced it received an FDA warning letter …

Benzinga | August 17, 2020

Edited Transcript of TRIB earnings conference call or presentation 27-May-20 3:00pm GMT

Q1 2020 Trinity Biotech PLC Earnings Call

Yahoo | July 24, 2020

Read More 'TRIB' Stories Here

TRIB Price Returns

1-mo 42.36%
3-mo 131.61%
6-mo 174.23%
1-year 349.16%
3-year -8.40%
5-year -61.16%
YTD 332.55%
2019 -54.87%
2018 -55.10%
2017 -26.30%
2016 -41.16%
2015 -32.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7905 seconds.